X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3035) 3035
Newsletter (2573) 2573
Book Review (283) 283
Newspaper Article (223) 223
Magazine Article (153) 153
Publication (89) 89
Transcript (60) 60
Trade Publication Article (14) 14
Conference Proceeding (12) 12
Dissertation (7) 7
Book / eBook (5) 5
Book Chapter (5) 5
Report (4) 4
Web Resource (3) 3
Data Set (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
antiulcer drugs (4978) 4978
index medicus (1881) 1881
humans (1218) 1218
helicobacter pylori (1129) 1129
research (1113) 1113
male (1071) 1071
universities and colleges (963) 963
medical research (876) 876
reports (864) 864
female (838) 838
medicine, experimental (834) 834
care and treatment (787) 787
ulcers (693) 693
drugs (671) 671
animals (660) 660
gastroenterology & hepatology (651) 651
pharmacology & pharmacy (638) 638
health aspects (637) 637
peptic ulcer (605) 605
helicobacter infections (580) 580
analysis (576) 576
rats (550) 550
middle aged (548) 548
infection (543) 543
pharmaceutical industry (484) 484
adult (473) 473
gastroesophageal reflux (447) 447
aged (397) 397
cancer (354) 354
drug therapy (321) 321
anti-ulcer agents - pharmacology (305) 305
chemistry, medicinal (290) 290
anti-ulcer agents - therapeutic use (286) 286
microbiology (269) 269
antiulcer activity (265) 265
amoxicillin (263) 263
antiulcer (261) 261
abridged index medicus (259) 259
stomach ulcer (258) 258
risk factors (253) 253
medicine & public health (250) 250
helicobacter infections - drug therapy (248) 248
stomach cancer (239) 239
gastrointestinal diseases (235) 235
stomach ulcer - drug therapy (231) 231
antiulcer agents (230) 230
treatment outcome (230) 230
rats, wistar (228) 228
mice (221) 221
gastric mucosa - drug effects (214) 214
helicobacter infections - microbiology (214) 214
omeprazole (212) 212
clinical trials (196) 196
stomach ulcer - chemically induced (196) 196
gastroenterology (191) 191
aspirin (190) 190
drug resistance in microorganisms (184) 184
plant extracts - pharmacology (183) 183
plant sciences (183) 183
prevalence (182) 182
communicable diseases (181) 181
disease (178) 178
helicobacter pylori - drug effects (176) 176
surgery (176) 176
ethanol (175) 175
infections (175) 175
prevention (173) 173
eradication (171) 171
helicobacter pylori - isolation & purification (170) 170
integrative & complementary medicine (165) 165
adolescent (163) 163
gastric mucosa - pathology (163) 163
indomethacin (163) 163
antibiotics (158) 158
helicobacter infections - complications (158) 158
proton pump inhibitors (158) 158
enzymes (157) 157
aged, 80 and over (156) 156
antioxidants (154) 154
endoscopy (154) 154
drug therapy, combination (152) 152
pharmacology (151) 151
medical colleges (149) 149
young adult (149) 149
disease models, animal (145) 145
dose-response relationship, drug (141) 141
inflammation (141) 141
gastritis (140) 140
prospective studies (140) 140
anti-bacterial agents - therapeutic use (139) 139
scientists (139) 139
stomach ulcer - prevention & control (137) 137
epidemiology (136) 136
stomach (136) 136
plant extracts - therapeutic use (135) 135
therapy (135) 135
ulcer (135) 135
diagnosis (128) 128
urea (128) 128
physiological aspects (127) 127
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6026) 6026
Japanese (18) 18
Portuguese (9) 9
Spanish (5) 5
German (4) 4
French (2) 2
Russian (2) 2
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 2010, Volume 5, Issue 3, pp. e9836 - e9836
Antibiotic administration is the standard treatment for the bacterium Helicobacter pylori, the main causative agent of peptic ulcer disease and gastric cancer.... 
CLARITHROMYCIN | RESISTANCE GENES | INTESTINAL MICROFLORA | HELICOBACTER-PYLORI INFECTION | FLORA | PERSISTENCE | BIOLOGY | POPULATIONS | MACROLIDE RESISTANCE | GRADIENT GEL-ELECTROPHORESIS | 16S RIBOSOMAL-RNA | Oligonucleotides - genetics | Dyspepsia - drug therapy | Humans | Metronidazole - administration & dosage | Omeprazole - administration & dosage | Gastrointestinal Tract - microbiology | Gastrointestinal Tract - drug effects | Drug Resistance, Microbial - genetics | Phylogeny | Case-Control Studies | Anti-Bacterial Agents - therapeutic use | Polymorphism, Restriction Fragment Length | Time Factors | Clarithromycin - administration & dosage | RNA, Ribosomal, 16S - genetics | Feces | Pharynx - drug effects | Pharynx - microbiology | Drug resistance in microorganisms | Care and treatment | Antibiotics | Microbiota (Symbiotic organisms) | RNA | Analysis | Peptic ulcer | Stomach cancer | Antiulcer drugs | Short term | Microbial activity | Clarithromycin | rRNA 16S | Microbiology | Genes | Colorectal cancer | Biology | Drug resistance | Gene polymorphism | Data bases | Microorganisms | Helicobacter pylori | Intestine | Antibiotic resistance | Phylogenetics | Bacteria | Gastric cancer | Deoxyribonucleic acid--DNA | Pharynx | Disease control | Bacteriology | Polymerase chain reaction | Infectious diseases | Restriction fragment length polymorphism | Metronidazole | Cancer | Long-term effects | Polymorphism | Index Medicus | ULCERS | ANTIBIOTICS | DISEASES | THERAPY | NEOPLASMS | GENES | FECES | COMMUNITIES | METRONIDAZOLE | Microbial/genetics | Ribosomal | Pharynx/drug effects/microbiology | Restriction Fragment Length | Gastrointestinal Tract/drug effects/microbiology | Clarithromycin/administration & dosage | Omeprazole/administration & dosage | Metronidazole/administration & dosage | Oligonucleotides/genetics | Naturvetenskap | Natural Sciences | Dyspepsia/drug therapy | 16S/genetics | Anti-Bacterial Agents/therapeutic use | Drug Resistance | Deoxyribonucleic acid | DNA
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2013, Volume 8, Issue 7, pp. e68917 - e68917
The most evident challenge to treatment of Helicobacter pylori, a bacterium responsible for gastritis, peptic ulcers and gastric cancer, is the increasing rate... 
MYCOBACTERIUM-TUBERCULOSIS | COMPLETE GENOME SEQUENCE | STREPTOCOCCUS-PNEUMONIAE | EPITHELIAL-CELLS | PSEUDOMONAS-AERUGINOSA | MULTIDISCIPLINARY SCIENCES | RANDOMIZED CLINICAL-TRIAL | ANTIBIOTIC-RESISTANCE | AMOXICILLIN RESISTANCE | TREATMENT FAILURE | RESCUE THERAPY | Duodenitis - complications | Humans | Helicobacter Infections - complications | Helicobacter pylori - drug effects | Microbial Sensitivity Tests | Stomach Ulcer - complications | Helicobacter Infections - drug therapy | Chloramphenicol - pharmacology | Gastritis - microbiology | Cell Membrane - drug effects | Adamantane - analogs & derivatives | Duodenitis - microbiology | Gastritis - drug therapy | Adamantane - pharmacology | Gastritis - complications | Helicobacter pylori - growth & development | Antitubercular Agents - pharmacology | Stomach Ulcer - drug therapy | Duodenitis - drug therapy | Helicobacter pylori - ultrastructure | Cell Membrane - ultrastructure | Microscopy, Electron | Duodenal Ulcer - microbiology | Ethylenediamines - pharmacology | Stomach Ulcer - microbiology | Metronidazole - pharmacology | Drug Synergism | Duodenal Ulcer - complications | Amoxicillin - pharmacology | Duodenal Ulcer - drug therapy | Helicobacter pylori - isolation & purification | Clarithromycin - pharmacology | Drug Resistance, Multiple, Bacterial - drug effects | Helicobacter Infections - microbiology | Hydrogen-Ion Concentration | Medical research | Medical colleges | Drug resistance in microorganisms | Ethylene | Peptic ulcer | Stomach cancer | Patient compliance | Ethylenediamines | Antiulcer drugs | Tuberculosis | Helicobacter pylori | Medicine, Experimental | Antitubercular agents | Health aspects | Drugs | Health sciences | Clarithromycin | Antimicrobial activity | Clinical trials | Clinical isolates | Genomes | Drug resistance | Drug development | pH effects | Thermal stability | Streptococcus infections | Immunology | Peptic ulcers | Gastroenterology | Bacteria | Pretreatment | Strains (organisms) | Gastric cancer | Killing | Pathogens | Stomach | Bacterial infections | Multidrug resistance | Oral administration | Rats | Cell division | Chloramphenicol | Cultures | Pharmacology | Bioavailability | Electron microscopy | Bactericidal activity | Ethane | Gastritis | Medicine | Dilution | Antibiotics | Ulcers | Amoxicillin | Minimum inhibitory concentration | Kinetics | Metronidazole | Rifampin | Cancer | Index Medicus
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2012, Volume 59, Issue 14, pp. 1304 - 1311
Journal Article
Clinical Gastroenterology and Hepatology, ISSN 1542-3565, 2010, Volume 8, Issue 1, pp. 36 - 41.e1
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2012, Volume 7, Issue 4, pp. e35072 - e35072
H. pylori drug-resistant strains and non-compliance to therapy are the major causes of H. pylori eradication failure. For some bacterial species it has been... 
RESPONSES | POLYUNSATURATED FATTY-ACIDS | INFECTION | MONOGLYCERIDES | STRAIN | BIOLOGY | Gastritis - drug therapy | Gastric Mucosa - microbiology | Mice, Inbred C57BL | Helicobacter pylori - ultrastructure | Gastric Mucosa - pathology | Helicobacter pylori - drug effects | Male | Docosahexaenoic Acids - administration & dosage | Helicobacter Infections - pathology | Docosahexaenoic Acids - pharmacology | Animals | Gastritis - pathology | Helicobacter Infections - drug therapy | Gastritis - microbiology | Anti-Bacterial Agents - pharmacology | Mice | Anti-Bacterial Agents - administration & dosage | Helicobacter Infections - microbiology | Unsaturated fatty acids | Helicobacter pylori | Growth | Analysis | Helicobacter infections | Health aspects | Omega-3 fatty acids | Antiulcer drugs | Therapy | Stomach | Disease | Fish oils | Mucosa | Gastric mucosa | Infections | Drug resistance | Docosahexaenoic acid | Fatty acids | Stomach cancer | Inflammatory diseases | Medicine | Studies | Pathology | Immunology | Antibiotics | Ulcers | Biomarkers | Bacteria | In vivo methods and tests | Colonization | Index Medicus | Helicobacter Infections/drug therapy | Docosahexaenoic Acids/administration & dosage | Anti-Bacterial Agents/administration & dosage | Helicobacter Infections/pathology | Helicobacter Infections/microbiology | Gastritis/drug therapy | Anti-Bacterial Agents/pharmacology | Bacteriology | Helicobacter pylori/drug effects | Helicobacter pylori/ultrastructure | Gastritis/pathology | Life Sciences | Microbiology and Parasitology | Human health and pathology | Gastritis/microbiology | Infectious diseases | Gastric Mucosa/microbiology | Gastric Mucosa/pathology
Journal Article
Digestive Diseases and Sciences, ISSN 0163-2116, 12/2014, Volume 59, Issue 12, pp. 2927 - 2934
Journal Article
Archiv der Pharmazie, ISSN 0365-6233, 07/2019, Volume 352, Issue 7, pp. 1800339 - n/a
Ketoprofen belongs to one of the most common nonsteroidal anti‐inflammatory drugs (NSAIDs) but its clinical usefulness has been restricted due to the high... 
ketoprofen | anti‐inflammatory | analgesic | antiulcer | enzymatic hydrolysis | codrug | anti-inflammatory | Antioxidants | Hydrolysis | Enzymes | Analysis | Gastrointestinal diseases | Nuclear magnetic resonance spectroscopy | Mass spectrometry | Ketoprofen
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 388, Issue 10058, pp. 2355 - 2365
Summary Background Whether concomitant therapy is superior to bismuth quadruple therapy or 14-day triple therapy for the first-line treatment of Helicobacter... 
Internal Medicine | CLARITHROMYCIN | ESOMEPRAZOLE | MEDICINE, GENERAL & INTERNAL | METAANALYSIS | EFFICACY | GASTRIC-CANCER | RESISTANCE | SEQUENTIAL THERAPY | INFECTION | ERADICATION | METRONIDAZOLE | Humans | Middle Aged | Helicobacter pylori - drug effects | Male | Antacids - therapeutic use | Anti-Bacterial Agents - therapeutic use | Proton Pump Inhibitors - administration & dosage | Metronidazole - therapeutic use | Helicobacter Infections - drug therapy | Clarithromycin - administration & dosage | Organometallic Compounds - therapeutic use | Female | Urea - metabolism | Amoxicillin - administration & dosage | Lansoprazole - administration & dosage | Drug Administration Schedule | Metronidazole - administration & dosage | Breath Tests | Tetracycline - therapeutic use | Clarithromycin - therapeutic use | Proton Pump Inhibitors - therapeutic use | Amoxicillin - therapeutic use | Taiwan | Drug Therapy, Combination - statistics & numerical data | Lansoprazole - therapeutic use | Antacids - administration & dosage | Anti-Bacterial Agents - administration & dosage | Tetracycline - administration & dosage | Organometallic Compounds - administration & dosage | Clinical trials | Medical colleges | Helicobacter infections | Care and treatment | Helicobacter pylori | Antiulcer drugs | Analysis | Bacteria | Bacterial infections | Antibiotics | Drug resistance | Drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
Journal of the American Chemical Society, ISSN 0002-7863, 05/2011, Volume 133, Issue 19, pp. 7355 - 7357
Bismuth-based drugs have long been used for the treatment of Helicobacter pylori infection. In this work, the metal content in H. pylori was monitored at the... 
CHEMISTRY | HOMEOSTASIS | IRON | IONOMICS | PROTEINS | CHEMISTRY, MULTIDISCIPLINARY | Anti-Ulcer Agents - pharmacokinetics | Bismuth - pharmacokinetics | Biological Transport | Helicobacter pylori - metabolism | Bismuth | Physiological aspects | Research | Helicobacter pylori | Magnesium compounds | Antiulcer drugs | Index Medicus
Journal Article